The project MOON aims at improving the diagnosis of major ophthalmic and neurodegenerative diseases through the development of disruptive optical technology.

MOON - Multimodal Optical Diagnosis of Ocular and Neurodegenerative Disease

The novel diagnostic platform combines the strength of complementary modalities, being Optical Coherence Tomography, Fluorescence Imaging, and Raman Spectroscopy.

MOON includes a validation of the multimodal diagnostic system in a clinical setting focusing on age-related macula degeneration and Alzheimer’s disease as surrogates for other major diseases affecting the human eye and the brain.

The eye serves as window to the brain, as the retinal neural tissue is equally affected by major neurodegenerative diseases as the brain tissue itself. Early signs of disease may therefore be diagnosed at an early state in a fully objective manner. This would have a huge societal impact on the quality of life of patients and their caretakers as well as on the national healthcare systems themselves.


photonics21This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 732969 (MOON). It is an initiative of the Photonics Public Private Partnership. www.photonics21.org



News

  • MOON has a stage in the Futuris series of Euronews in which the latest news about leading scientific and technological research projects in Europe is shared. Doctors, patients and technicians explain the aims and added values of the MOON project.

  • MOON held its fifth consortium meeting in Vienna. Part of the consortium meeting was a workshop on Ophthalmic and Neurodenererative Diseases and Diagnostic Instrumentation by Prof. Dr. Andreas Pollreisz and Prof. Rainer Leitgeb. October 4-5, 2018
  • The Midterm review in Brussels in July 2018 has been successfully passed – MOON starts with full enthusiasm into its second period

 

 

 

 

 

 
 

Quick Links

 
 

Featured